Skip to main content
. 2024 May 21;12(3):e004117. doi: 10.1136/bmjdrc-2024-004117

Table 3.

Differences and changes in metabolic health, C reactive protein (CRP), and bone density at 1 year postpartum according to breastfeeding category in women with prior GDM

n=171 BF <6
(n=69)
BF ≥6
(n=102)
Model 1* Model 2†
Mean±SD Mean±SD β (95% CI) P value β (95% CI) P value
Body composition
 Weight (kg) 78.6±17.9 68.5±14.0 −10.15 (−15.09, 5.21) <0.001 −3.44 (−6.08, −0.79) 0.01
 Weight retention (kg) 5.4±6.9 2.4±4.5 −2.92 (−4.66, 1.17) <0.01 −2.40 (−4.24, 0.56) 0.01
 Body fat (BIA, kg) 30.8±11.6 23.6±8.9 −7.11 (−10.29, 3.92) <0.001 −2.72 (−4.47, 0.98) <0.01
 Fat-free mass (BIA, kg) 47.9±7.2 44.1±5.4 −3.77 (−5.73, 1.82) <0.001 −1.55 (−2.93, 0.16) 0.03
ΔBody composition between 1 year and 6–8 weeks postpartum
 Weight difference (kg) 0.6±5.0 −1.7±4.3 −2.26 (−3.72, 0.80) <0.01 −1.57 (−3.07, 0.07) 0.04
 Body fat difference (BIA, kg) −0.2±4.3 −2.3±3.7 −2.09 (−3.34, 0.84) <0.01 −1.44 (−2.71, 0.18) 0.03
 Fat-free mass difference (BIA, kg) 0.7±2.4 0.1±2.5 −0.68 (−1.45, 0.08) 0.08 −0.55 (−1.36, 0.26) 0.18
Body composition by DEXA
 Body fat (kg) 31.5±12.4 25.1±10.0 −6.43 (−10.93, 1.93) 0.01 −2.46 (−4.83, 0.09) 0.04
 Lean mass (kg) 43.6±6.4 40.2±5.4 −2.82 (−5.19, 0.46) 0.02 −1.61 (−3.48, 0.26) 0.09
 Fat mass index (kg/m2) 11.5±4.5 9.4±3.7 −2.09 (−3.75, 0.43) 0.01 −0.64 (−1.43, 0.15) 0.11
 Visceral adipose tissue (kg) 0.7±0.5 0.5±0.4 −0.22 (−0.40, 0.03) 0.02 −0.07 (−0.17, 0.04) 0.20
Insulin resistance/secretion
 HOMA-IR 3.9±2.5 2.7±1.9 −1.25 (−1.94, 0.56) <0.001 −0.57 (−1.15, 0.01) 0.06
 HOMA-B 54.4±35.7 37.6±25.6 −16.82 (−26.38, 7.26) <0.01 −7.38 (−15.66, 0.89) 0.08
 Matsuda 4.8±3.7 6.0±3.4 1.22 (0.05, 2.39) 0.04 −0.14 (−1.13, 0.84) 0.77
 AUC 0.6±0.5 0.5±0.2 −0.15 (−0.27, 0.04) 0.01 −0.06 (−0.17, 0.05) 0.27
 ISSI-2 2.1±0.8 2.3±0.9 0.25 (−0.03, 0.53) 0.08 0.05 (−0.23, 0.33) 0.72
Inflammation
 CRP (mg/L)* 0.7 (−0.1, 1.6) 0.2 (−0.5, 0.9) −0.52 (−0.88, 0.15) 0.01 −0.37 (−0.73, 0.01) 0.04
 TNF-α (pg/mL)* −0.6 (0.9, –0.3) −0.7 (−1.1, –0.3) −0.10 (−0.35, 0.15) 0.42 −0.08 (−0.33, 0.17) 0.53
 IL-6 (pg/mL)* −0.5 (−1.1, 0.1) −0.7 (−1.1, 0.1) −0.21 (−0.57, 0.15) 0.25 −0.23 (−0.61, 0.16) 0.25
Bone density
 Bone mineral density (L1–L4, g/cm2) 1.176±0.096 1.169±0.147 −0.01 (−0.06, 0.04) 0.79 0.01 (−0.05, 0.06) 0.81
 T-score (L1–L4, g/cm2) −0.1±0.8 −0.1±1.2 −0.05 (−0.48, 0.38) 0.82 0.06 (−0.38, 0.50) 0.79
 Z-score (L1–L4, g/cm2) −0.1±0.8 −0.2±1.2 −0.10 (−0.53, 0.33) 0.65 −0.02 (−0.47, 0.42) 0.91

Data are expressed as mean±SD and β (95% CI). Data marked by * were log-transformed and are expressed as median (IQR).

*Adjusted for group allocation.

†Adjusted for group allocation, pre-pregnancy BMI, educational level, and glucose-lowering treatment in pregnancy.

AUC, area under the curve insulin/glucose; BF <6, no or <6 months of breastfeeding; BF ≥6, ≥6 months of breastfeeding; BIA, bioelectrical impedance analysis; BMI, body mass index; DEXA, dual-energy X-ray absorptiometry; GDM, gestational diabetes mellitus; HOMA-B, Homeostatic Model Assessment of β-cell index; HOMA-IR, Homeostatic Model Assessment for Insulin Resistance; IL-6, interleukin 6; ISSI-2, Insulin Secretion-Sensitivity Index-2; TNF-α, tumor necrosis factor α; Δ, change or difference.